NFKB1 and lung cancer: Ji et al. [67] showed that treatment of lung cancer cells with δ-T3 caused a reduction in NF-κB-DNA binding activity and down-regulation of NF-κB-dependent gene expression including genes coding for surviving, matrix metalloproteinase-9, vascular endothelial growth factor, and Bcl-xL.